EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model

T Mariager iD, J H Terkelsen iD, J M Guldbæk iD, M D Nielsen iD, J Vestergaard, M Bue iD, K Öbrink-Hansen iD, R Nau iD, C R Bjarkam iD, E C M de Lange, H Nielsen iD, J Bodilsen iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01811-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von T Mariager und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Acyclovir, Antiviral Agents, Central Nervous System, Encephalitis, Herpes Simplex. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus (HSV) encephalitis is a severe infection with high mortality and neurological sequelae if untreated. Intravenous acyclovir (ACV) is the standard treatment, but its central nervous system (CNS) penetration is not fully understood. To evaluate the distribution of ACV in various CNS compartments in a porcine pharmacokinetic model, 12 female pigs were divided into two groups: group I receiving a single ACV dose (10 mg/kg) and group II receiving three doses over 24 h. Microdialysis sampled unbound ACV concentrations in cortical and subcortical extracellular fluid (ECF), ventricular cerebrospinal fluid (CSF), and cisternal CSF. The ACV target concentration was defined as peak concentration ( f C max ) > inhibitory concentration 50% (IC 50 ) for HSV-1 at 0.56 µg/mL. Pharmacokinetic parameters, including f C max , time above IC 50 (T > IC 50 ), and area under the curve (AUC), were analyzed. The target ACV concentration ( f C max > 0.56 µg/mL) was achieved in all ECF and CSF compartments during the second and third dosing intervals. The T > IC 50 and AUC increased from the first to the third dose and were consistent across compartments. Intracerebral penetration ratios ( f AUC tissue / f AUC plasma ) during the third dose ranged from 0.18 to 0.32 within the CNS compartments. In conclusion, ACV administered intravenously at 10 mg/kg every eighth hour achieved therapeutic levels in porcine CNS compartments after the second dose, suggesting that current dosing regimens are effective in treating HSV encephalitis. However, the first dose may not reach therapeutic levels, suggesting that higher initial dosages or prolonged infusions should be considered. Further studies under inflammatory conditions are warranted to extrapolate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcyclovirAntiviral AgentsCentral Nervous SystemEncephalitis, Herpes SimplexAnimalsSwineFemaleHerpesvirus 1, HumanMicrodialysis

Stichwörter der Autor:innen

CNS PK/PDacyclovirantiviral agentsencephalitisherpes simplex viruspharmacokinetics

Substanzen

AcyclovirAntiviral Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Neurosurgery, Aalborg University Hospital, Aalborg, Denmark.
  • The ESCMID Study Group for Infectious Diseases of the Brain (ESGIB), European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
  • Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark.
  • Aarhus Denmark Microdialysis Research Group (ADMIRE), Aarhus University Hospital, Aarhus, Denmark.
  • Department of Internal Medicine, Gødstrup Hospital, Herning, Denmark.

ORCID-Profile: T Mariager, J H Terkelsen, J M Guldbæk, M D Nielsen, M Bue, K Öbrink-Hansen, R Nau, C R Bjarkam, H Nielsen, J Bodilsen

Zitieren

APA

Mariager, T., Terkelsen, J. H., Guldbæk, J. M., Nielsen, M. D., Vestergaard, J., Bue, M., Öbrink-Hansen, K., Nau, R., Bjarkam, C. R., de Lange, E. C. M., Nielsen, H., & Bodilsen, J. (2025). Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01811-24

Vancouver

Mariager T, Terkelsen JH, Guldbæk JM, Nielsen MD, Vestergaard J, Bue M, et al. Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01811-24

BibTeX
@article{Mariager2025,
  author = {Mariager, T and Terkelsen, J H and Guldbæk, J M and Nielsen, M D and Vestergaard, J and Bue, M and Öbrink-Hansen, K and Nau, R and Bjarkam, C R and de Lange, E C M and Nielsen, H and Bodilsen, J},
  title = {Distribution of acyclovir in central nervous system compartments: a porcine pharmacokinetic model},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01811-24}
}
Kostenlos starten →